These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 30791232)

  • 61. MicroRNA-206 attenuates tumor proliferation and migration involving the downregulation of NOTCH3 in colorectal cancer.
    Wang XW; Xi XQ; Wu J; Wan YY; Hui HX; Cao XF
    Oncol Rep; 2015 Mar; 33(3):1402-10. PubMed ID: 25607234
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The Plasma microRNA miR-1914* and -1915 Suppresses Chemoresistant in Colorectal Cancer Patients by Down-regulating NFIX.
    Hu J; Cai G; Xu Y; Cai S
    Curr Mol Med; 2016; 16(1):70-82. PubMed ID: 26695693
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The phosphoinositide hydrolase phospholipase C delta1 inhibits epithelial-mesenchymal transition and is silenced in colorectal cancer.
    Xiang Q; He X; Mu J; Mu H; Zhou D; Tang J; Xiao Q; Jiang Y; Ren G; Xiang T; Peng W
    J Cell Physiol; 2019 Aug; 234(8):13906-13916. PubMed ID: 30618183
    [TBL] [Abstract][Full Text] [Related]  

  • 64. miR-154 suppresses colorectal cancer cell growth and motility by targeting TLR2.
    Xin C; Zhang H; Liu Z
    Mol Cell Biochem; 2014 Feb; 387(1-2):271-7. PubMed ID: 24242044
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Long Noncoding RNA HOXD-AS1 Promotes the Proliferation, Migration, and Invasion of Colorectal Cancer via the miR-526b-3p/CCND1 Axis.
    Yan F; Ma Y; Liu L; Li L; Deng J; Sun J
    J Surg Res; 2020 Nov; 255():525-535. PubMed ID: 32640404
    [TBL] [Abstract][Full Text] [Related]  

  • 66. TSHZ3 functions as a tumor suppressor by DNA methylation in colorectal cancer.
    Zhou Y; Wang S; Yin X; Gao G; Wang Q; Zhi Q; Han Y; Kuang Y
    Clin Res Hepatol Gastroenterol; 2021 Nov; 45(6):101725. PubMed ID: 34089916
    [TBL] [Abstract][Full Text] [Related]  

  • 67. microRNA-16-5p-containing exosomes derived from bone marrow-derived mesenchymal stem cells inhibit proliferation, migration, and invasion, while promoting apoptosis of colorectal cancer cells by downregulating ITGA2.
    Xu Y; Shen L; Li F; Yang J; Wan X; Ouyang M
    J Cell Physiol; 2019 Nov; 234(11):21380-21394. PubMed ID: 31102273
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Regulation of UHRF1 by microRNA-9 modulates colorectal cancer cell proliferation and apoptosis.
    Zhu M; Xu Y; Ge M; Gui Z; Yan F
    Cancer Sci; 2015 Jul; 106(7):833-9. PubMed ID: 25940709
    [TBL] [Abstract][Full Text] [Related]  

  • 69. MiR-4500 is epigenetically downregulated in colorectal cancer and functions as a novel tumor suppressor by regulating HMGA2.
    Yu FY; Tu Y; Deng Y; Guo C; Ning J; Zhu Y; Lv X; Ye H
    Cancer Biol Ther; 2016 Nov; 17(11):1149-1157. PubMed ID: 27686621
    [TBL] [Abstract][Full Text] [Related]  

  • 70. MYC and DNMT3A-mediated DNA methylation represses microRNA-200b in triple negative breast cancer.
    Pang Y; Liu J; Li X; Xiao G; Wang H; Yang G; Li Y; Tang SC; Qin S; Du N; Zhang H; Liu D; Sun X; Ren H
    J Cell Mol Med; 2018 Dec; 22(12):6262-6274. PubMed ID: 30324719
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Fos-like antigen 2 (FOSL2) promotes metastasis in colon cancer.
    Li S; Fang XD; Wang XY; Fei BY
    Exp Cell Res; 2018 Dec; 373(1-2):57-61. PubMed ID: 30114390
    [TBL] [Abstract][Full Text] [Related]  

  • 72. miR-300 promotes proliferation and EMT-mediated colorectal cancer migration and invasion by targeting p53.
    Wang L; Yu P
    Oncol Rep; 2016 Dec; 36(6):3225-3232. PubMed ID: 27779716
    [TBL] [Abstract][Full Text] [Related]  

  • 73. MicroRNA-485-5p reduces O-GlcNAcylation of Bmi-1 and inhibits colorectal cancer proliferation.
    Chai Y; Du Y; Zhang S; Xiao J; Luo Z; He F; Huang K
    Exp Cell Res; 2018 Jul; 368(1):111-118. PubMed ID: 29680296
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Crocin Suppresses Colorectal Cancer Cell Proliferation by Regulating miR-143/145 and KRAS/RREB1 Pathways.
    Hosseini SS; Nazifi P; Amini M; Zargari F; Yari AH; Baradaran B; Mahboob S; Mokhtarzadeh A
    Anticancer Agents Med Chem; 2023; 23(17):1916-1923. PubMed ID: 37464834
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Long non-coding RNA TP73-AS1 sponges miR-194 to promote colorectal cancer cell proliferation, migration and invasion via up-regulating TGFα.
    Cai Y; Yan P; Zhang G; Yang W; Wang H; Cheng X
    Cancer Biomark; 2018; 23(1):145-156. PubMed ID: 30010111
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Aberrantly expressed Fra-1 by IL-6/STAT3 transactivation promotes colorectal cancer aggressiveness through epithelial-mesenchymal transition.
    Liu H; Ren G; Wang T; Chen Y; Gong C; Bai Y; Wang B; Qi H; Shen J; Zhu L; Qian C; Lai M; Shao J
    Carcinogenesis; 2015 Apr; 36(4):459-68. PubMed ID: 25750173
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Hypomethylation of GDNF family receptor alpha 1 promotes epithelial-mesenchymal transition and predicts metastasis of colorectal cancer.
    Dong Z; Dai L; Zhang Y; Fang C; Shi G; Chen Y; Li J; Wang Q; Fu J; Yu Y; Wang W; Cheng L; Liu Y; Lin Y; Wang Y; Wang Q; Wang H; Zhang H; Zhang Y; Su X; Zhang S; Wang F; Qiu M; Zhou Z; Deng H
    PLoS Genet; 2020 Nov; 16(11):e1009159. PubMed ID: 33175846
    [TBL] [Abstract][Full Text] [Related]  

  • 78. microRNA-27a functions as a tumor suppressor in esophageal squamous cell carcinoma by targeting KRAS.
    Zhu L; Wang Z; Fan Q; Wang R; Sun Y
    Oncol Rep; 2014 Jan; 31(1):280-6. PubMed ID: 24154848
    [TBL] [Abstract][Full Text] [Related]  

  • 79. MicroRNA Expression in
    Lundberg IV; Wikberg ML; Ljuslinder I; Li X; Myte R; Zingmark C; Löfgren-Burström A; Edin S; Palmqvist R
    Anticancer Res; 2018 Feb; 38(2):677-683. PubMed ID: 29374690
    [TBL] [Abstract][Full Text] [Related]  

  • 80. MiR-134/487b/655 cluster regulates TGF-β-induced epithelial-mesenchymal transition and drug resistance to gefitinib by targeting MAGI2 in lung adenocarcinoma cells.
    Kitamura K; Seike M; Okano T; Matsuda K; Miyanaga A; Mizutani H; Noro R; Minegishi Y; Kubota K; Gemma A
    Mol Cancer Ther; 2014 Feb; 13(2):444-53. PubMed ID: 24258346
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.